Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05661084 · ClinicalTrials.gov registry record · NA
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
A NA study of Alzheimer Disease and Dementia, sponsored by Hebrew SeniorLife.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT05661084: Recruiting NA study of Alzheimer Disease and Dementia, sponsored by Hebrew SeniorLife.
NCT05661084 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Hebrew SeniorLife. The registered enrollment target is 144 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05661084, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Hebrew SeniorLife.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.
Primary Outcome
This test is designed to evaluate verbal memory in those 16 years of age and older. It can be used to evaluate the nature and severity of memory dysfunction and to track changes in memory function over time. Total recall is measured by the total number of words out of 15 the participant is able to recall. Scores range from 0 to 15.
Conditions Studied
Interventions
- DEVICE Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active)
- DEVICE Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham)
- DEVICE Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham)
- DEVICE Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active)
Study Locations (1)
Massachusetts
- Hinda and Arthur Marcus Institute for Aging Research - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2023-01-24 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT05661084 shows while recruiting
NCT05661084 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 4 interventions - of which Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active) is the first listed.
NCT05661084 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05661084 about?
NCT05661084 is a clinical study titled "Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia". This project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.
What is the current status of trial NCT05661084?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2023-01-24. Estimated completion is 2027-08-31.
What conditions does trial NCT05661084 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Mobility Limitation, Executive Dysfunction, Memory Loss.
What interventions are being tested in trial NCT05661084?
The interventions under investigation include: Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active) (DEVICE), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham) (DEVICE), Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham) (DEVICE), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active) (DEVICE).
Who is sponsoring clinical trial NCT05661084?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05661084 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05661084's enrollment target sits among peer trials
144 133rd of 306 higher than 173 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI